Brief Telehealth Screening of MS Patients in the Medical Setting
Background: A significant clinical need exists for a broad range of health care professionals to be able to objectively screen for the...
Geographic Variance of MS Prevalence in the United States
Background: The etiology of multiple sclerosis (MS) is not fully understood, and the disease may be triggered or exacerbated by...
Connect Trial of Online Professional Support Groups for Black and Latinx People Living with MS
Background: Given the high prevalence of anxiety and depression in MS, many patients struggle to find high quality, professional mental...
Temporal Trends in Humoral and Cellular Immune Responses to Sars-Cov-2 mRNA Vaccines Among Multiple Sclerosis Patients Treated with Natalizumab, Ocrelizumab or Fumarates
Background: Vaccines against SARS-CoV-2 are a key component of public health measures to combat the COVID-19 pandemic. The impact of...
Dimethyl Fumarate Is Associated with Lower Rates of Infection and Lower Infection-Related Healthcare Costs When Compared with Ocrelizumab
Background: Infections in people with multiple sclerosis (PwMS) may have a detrimental effect on disease progression, risk of...
Evaluating the Impact of Administering Ocrelizumab Via a Home Infusion on Safety and Patient Reported Outcomes
Background: US payers are looking to reduce the cost of administering infusible drugs for multiple sclerosis (MS). Home-based infusion has...
Patient-Centered Education and Care Coordination Initiative to Improve Self-Management Skills in Latinos with Multiple Sclerosis
Background: Multiple sclerosis (MS) is a chronic, disabling neurological disease that attacks young adults. Similar to many other chronic...
US Real World Experience Switching from Infusion and S1P Therapies to Cladribine Tablets: A Single Center Study
Background: Multiple sclerosis (MS) is a chronic neurological disorder and a major cause of disability in young adults. Cladribine tablets...
Early Experience with Cladribine Tablets in an Aging Patient Population
Background: Cladribine, a deoxyadenosine analogue prodrug that preferentially depletes lymphocytes, may disrupt the central immune cascade...
Humoral and T-Cell Responses to Sars-Cov-2 Vaccination in Multiple Sclerosis Patients Treated with Ocrelizumab
Background: The COVID-19 epidemic raises important questions about the efficacy of vaccines for people treated with ocrelizumab (OCR), an...